1Villeneuve JP, Condreay LD, Willems B, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology,2000,31: 207-210.
2Kapoor D, Guptan RC, Wakil SM. Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol, 2000,33:308-312.
8Schiff E, Karayalcin S, Grimm I,et al. A Placebo controlled strdy of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon therapy[J]. Hepatology, 1998,28 (4) :2:388A.
9LiawYF, Lai CL, Leung NWY, et al. Two years lamivudine therapy in chronic hepatitis B infection:results of a placebo-controlled multicentre study in Asia [ J ]. Gastroenterol, 1998,114(2):A1289.
10Tiples GA,Am MM,Fischer KP,et al. Mutation in HBV RNA-Dependent DNA Polymerase Coders Resistance to Lamivadine In Vivo[J]. Hepatology, 1996,24(3) :714-717.
